5-HYDROXYTRYPTOPHAN - METHOD FOR MONITORING HUMAN-PLASMA CONTENT DURING CLINICAL ADMINISTRATION

被引:5
作者
ANGWIN, P
BERGER, P
ZARCONE, V
BRODIE, HKH
BARCHAS, J
机构
[1] STANFORD UNIV,SCH MED,DEPT PSYCHIAT & BEHAV SCI,STANFORD,CA 94305
[2] DUKE UNIV,DEPT PSYCHIAT,DURHAM,NC 27706
关键词
D O I
10.1007/BF00965605
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:649 / 657
页数:9
相关论文
共 28 条
[1]  
APRISON MH, 1974, SEROTONIN NEW VISTAS, V11, P31
[3]  
BARCHAS J, 1973, SEROTONIN BEHAVIOR
[4]  
BAZELON M, 1968, Brain Research, V11, P397, DOI 10.1016/0006-8993(68)90033-4
[5]  
Brodie HKH, 1973, SEROTONIN BEHAVIOR, P549
[6]  
CHASE TN, 1970, LANCET, V2, P1029
[7]  
CHASE TN, 1970, LANCET, V2, P1030
[8]  
GUILBAULT GG, 1974, CLIN CHEM, V20, P812
[9]   EFFECTS OF 5-HYDROXYTRYPTOPHAN ON SLEEP OF A PATIENT WITH A BRAIN-STEM LESION [J].
GUILLEMINAULT, C ;
CATHALA, JP ;
CASTAIGNE, P .
ELECTROENCEPHALOGRAPHY AND CLINICAL NEUROPHYSIOLOGY, 1973, 34 (02) :177-184
[10]  
GUILLEMINAULT C, 1973, SEROTONIN BEHAVIOR, P443